IVX-411
id:
ivx-411-166-14040118
title:
IVX-411
text:
IVX-411 is a COVID-19 candidate nanoparticle vaccine under development by Icosavax currently undergoing a Phase I/II clinical trial in Australia. It was originally developed at the Institute of Protein Design (IPD) and the University of Washington School of Medicine, both based at the University of Washington.
brand slug:
wiki
category slug:
encyclopedia
description:
COVID-19 nanoparticle vaccine candidate
original url:
https://en.wikipedia.org/wiki/IVX-411
date created:
2021-08-18T10:34:43Z
date modified:
2024-08-30T00:41:58Z
main entity:
{"identifier":"Q108377383","url":"https://www.wikidata.org/entity/Q108377383"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/94/Coronavirus._SARS-CoV-2.png","width":2048,"height":2048}
fields total:
13
integrity:
16